Table: Cosmos Pharmaceutical - 6-MTH group results
Jan 13 (Reuters)-
Cosmos Pharmaceutical Corp.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Nov 30, 2022 Nov 30, 2021 May 31, 2023
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 404.02 371.14 813.50
(+8.9 pct) (+7.7 pct)
Operating 15.39 14.98 30.00
(+2.7 pct) (+0.7 pct)
Recurring 16.90 16.49 33.00
(+2.5 pct) (+0.4 pct)
Net 11.30 11.25 23.20
(+0.5 pct) (+0.2 pct)
EPS 285.34 yen 283.99 yen 585.87 yen
Ann Div 80.00 yen 85.00 yen
-Q2 div 42.50 yen 40.00 yen
-Q4 div 40.00 yen 42.50 yen
NOTE - Cosmos Pharmaceutical Corp..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T